Question explored with the scientific record
Could ivermectin paste applied topically help my sore lower back
The short version: the evidence for ivermectin paste on a sore lower back exists for parasites and inflammation in rosacea, but not for muscle pain or back strain.
None of the studies you cited tested ivermectin for back pain. The 2018 rosacea guideline mentions ivermectin 1% cream as having anti-inflammatory effects against Demodex mites, but that is skin inflammation on the face, not muscle or nerve pain in the back [1]. The 2015 scabies study compared topical to oral ivermectin for parasite eradication on the skin, again not for musculoskeletal pain [5]. The 2020 and 2024 papers are formulation chemistry—they show ivermectin can be delivered through skin at high flux using special nano-carriers [2, 4] and a gel killed ticks on rabbit ears [3]. None measured pain relief, inflammation markers in muscle, or any back-pain outcome.
Your hypothesis that ivermectin's anti-inflammatory properties might treat back pain is a guess, not supported by a single human trial. The rabbit tick study [3] used 3 rabbits per group and measured tick counts, not pain. The skin delivery papers [2, 4] prove the drug can get through skin; they don't prove it does anything useful once it gets there.
| What it was tested for | Population | Outcome measured | Evidence quality |
|---|---|---|---|
| Rosacea (facial skin inflammation) | Humans | Erythema, papules, pustules | Clinical guideline [1] |
| Scabies (skin mite infestation) | Humans | Parasite cure rate | RCT, 62 patients [5] |
| Tick infestation (rabbit ear) | 6 rabbits | Tick count reduction | Small animal study [3] |
| Skin permeation (lab skin) | Pig/human skin in dish | Drug flux through skin | Ex vivo formulation [2, 4] |
| Lower back pain | Nobody | Not studied | No evidence |
My call: no human trial has tested topical ivermectin for back pain, and the existing studies address different conditions. This is an untested idea with no safety data for this use, and there is no reason to believe the paste you have was formulated for human skin at the right dose. Confidence: not clear—the gap is total.
Sources examined 5
-
An update on the treatment of rosacea
A narrative clinical guideline/review on rosacea covering diagnosis, subtypes, and evidence-based management strategies including topical therapies, systemic antibiotics, isotretinoin, laser/physical modalities, ocular rosacea, triggers, skin care, and patient education.
DOI: 10.18773/austprescr.2018.004 -
Development of microemulsion based topical ivermectin formulations: Pre-formulation and formulation studies
This study developed microemulsion and microemulsion gel formulations for the topical delivery of ivermectin, demonstrating improved stability and permeation compared to traditional formulations.
DOI: 10.1016/j.colsurfb.2020.110823 -
Comparative Evaluation Of Ivermectin Topical Gel And Reported Formulations: Anti-Tick Efficacy Assessment At 12 Hours
A small in vivo study in rabbits demonstrates that a specially formulated ivermectin topical gel (F3) provides superior anti-tick activity at 12 hours compared with marketed ivermectin tablets and subcutaneous forms, due to enhanced skin penetration, sustained release, and prolo…
DOI: 10.64252/gg4p7t76 -
Formulation and Ex Vivo Evaluation of Ivermectin Within Different Nano-Drug Delivery Vehicles for Transdermal Drug Delivery
This study investigates the formulation and ex vivo evaluation of ivermectin using various nano-drug delivery vehicles, demonstrating their effectiveness in transdermal drug delivery with minimal cytotoxicity.
DOI: 10.3390/pharmaceutics16111466 -
Clinical efficacy and safety of topical versus oral ivermectin in treatment of uncomplicated scabies
This study compares the efficacy and safety of topical versus oral ivermectin in treating uncomplicated scabies, finding both treatments to be equally effective and safe, with a high cure rate after one week.
DOI: 10.1111/dth.12310